These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7916408)

  • 21. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
    Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
    J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spontaneous regression of cancer.
    Papac RJ
    Cancer Treat Rev; 1996 Nov; 22(6):395-423. PubMed ID: 9134002
    [No Abstract]   [Full Text] [Related]  

  • 23. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
    Bourhis J; Bénard J; DeVathaire F; Wilson GD; Hartmann O; Terrier-Lacombe MJ; Boccon-Gibod L; Lemerle J; Riou G
    Prog Clin Biol Res; 1991; 366():107-13. PubMed ID: 2068130
    [No Abstract]   [Full Text] [Related]  

  • 24. [Expression of CD44-standard in 182 primary neuroblastomas].
    Christiansen H; Terpe HJ; Gonzales M; Wenderhold S; Berthold F; Lampert F
    Klin Padiatr; 1995; 207(4):219-21. PubMed ID: 7564156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of PPAR-gamma is correlated with the clinical course of neuroblastoma.
    Sato Y; Sasaki H; Kobayashi Y; Haruki N; Toyama T; Kondo S; Fujii Y
    J Pediatr Surg; 2003 Feb; 38(2):205-10. PubMed ID: 12596104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroblastoma.
    Black CT; Atkinson JB
    Semin Pediatr Surg; 1997 Feb; 6(1):2-10. PubMed ID: 9117270
    [No Abstract]   [Full Text] [Related]  

  • 27. Association among EPHB2, TrkA, and MYCN expression in low-stage neuroblastomas.
    Tang XX; Evans AE; Zhao H; Cnaan A; Brodeur GM; Ikegaki N
    Med Pediatr Oncol; 2001 Jan; 36(1):80-2. PubMed ID: 11464911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [N-myc status of neuroblastoma from bone marrow cells].
    Brack T; Finckenstein FG; Kabisch H
    Klin Padiatr; 1991; 203(4):323-7. PubMed ID: 1942939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
    Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
    N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastoma.
    Coco S; Theissen J; Scaruffi P; Stigliani S; Moretti S; Oberthuer A; Valdora F; Fischer M; Gallo F; Hero B; Bonassi S; Berthold F; Tonini GP
    Int J Cancer; 2012 Oct; 131(7):1591-600. PubMed ID: 22234802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inverse expression of MYCN and mdr-1 in human neuroblastoma.
    Nakagawara A; Kadomatsu K; Sato S; Kohno K; Takano H; Kuwano M
    Prog Clin Biol Res; 1991; 366():11-9. PubMed ID: 2068131
    [No Abstract]   [Full Text] [Related]  

  • 32. Predicting outcome in neuroblastoma.
    Castleberry RP
    N Engl J Med; 1999 Jun; 340(25):1992-3. PubMed ID: 10379025
    [No Abstract]   [Full Text] [Related]  

  • 33. [Gene regulation during NGF--induced differentiation of neuroblastoma cells].
    Chen J
    Zhonghua Bing Li Xue Za Zhi; 1991 Mar; 20(1):7-10. PubMed ID: 2065383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [N-myc gene copies in children with neuroblastoma and its clinical significance].
    Ma XL; Gong LP; Zhou CJ; Zhang DW; Jin M; Wang HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1447-51. PubMed ID: 23257451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Free DNA in the blood serum can unmask MYCN amplified tumors.
    Ambros PF; Ambros IM
    Pediatr Blood Cancer; 2009 Sep; 53(3):306-7. PubMed ID: 19489051
    [No Abstract]   [Full Text] [Related]  

  • 36. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification.
    Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M
    J Pediatr Surg; 2000 Dec; 35(12):1737-41. PubMed ID: 11101726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The MYCN oncogene and differentiation in neuroblastoma.
    Westermark UK; Wilhelm M; Frenzel A; Henriksson MA
    Semin Cancer Biol; 2011 Oct; 21(4):256-66. PubMed ID: 21849159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes.
    Warnat P; Oberthuer A; Fischer M; Westermann F; Eils R; Brors B
    BMC Cancer; 2007 May; 7():89. PubMed ID: 17531100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonality analysis of childhood neuroblastoma by polymerase chain reaction for the human androgen receptor gene.
    Shen L; Wu Z; Kuroda T; Honna T; Tanaka Y; Miyauchi J
    Int J Oncol; 2005 May; 26(5):1329-35. PubMed ID: 15809725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of heterozygosity on chromosome 14 in neuroblastoma.
    Suzuki T; Mugishima H; Fujisawa T; Okuni M; Okabe I; Yokota J; Terada M
    Prog Clin Biol Res; 1991; 366():135-45. PubMed ID: 2068134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.